Here we reveal that ARC mediates a complex regulatory circuit likely via NFκB/IL1β signaling in both AML cells and MSCs, leading to activation of numerous chemokine ligand/receptor axes that foster their close association and leukemic cell chemoresistance, therefore a novel target for AML. This evidence concerns the gene NFKB1 and acute myeloid leukemia.